The Alliance

Spotlight Series

The Alliance Spotlight Series is a recurring one-page publication for front-line healthcare professionals, offering quick-takes on critical topics affecting the field of organ donation and transplantation. We encourage you to download these issues and share them with your front-line colleagues and partners.

Spotlight Series Past Issues

Exclusive Access

Take advantage of our professional partnership levels of support to receive exclusive early access to The Alliance Insight Series publications.

You’ll still have access to all our materials when they go online one month after publication.

DermatologySkinEvaluation
Following transplantation, the recipient’s need for immunosuppression medications can lead to an increased risk of infections and certain cancers.

Post-Transplant Skin Cancer in Recipients: Early Detection and Prevention

While organ transplantation can significantly improve the quality of life of critically ill patients, it comes with substantial risks that transplant recipients should be aware of. Following transplantation, the recipient’s need for immunosuppression medications can lead to an increased risk of infections and certain cancers. For transplant recipients, the risk of skin cancer can be up to 100-fold higher. Pre-transplant screening and patient education are essential components of the evaluation process for potential recipients and require a team approach by dermatology and the transplant care providers.

Cancer Table

Preventive Treatment of Skin Cancer

The management of skin cancer in transplant patients follows the same principles as with all patients susceptible to skin cancer, but with a heightened sense of importance. Outdoor activities should be scheduled earlier or later in the day rather than during the peak sun hours of 10am to 4pm. Broad spectrum sunscreen with a sun protection factor of 30 or greater should be applied to all exposed skin surfaces as part of the daily morning routine and reapplied when in the sun. Transplant patients should also be advised not to seek a tan via natural or artificial ultraviolet exposure. Sun Protective Gear such as hats, clothing, and sunglasses are important and highly encouraged.

DemographicsTransplant recipients concerned about skin cancer should consider exploring treatments that can help reverse sun damage. Potential treatments include excision, a light-based therapy known as photodynamic therapy, and topical medications such as the chemotherapy drug 5-fluorouracil or the immuneboosting therapy imiquimod. Physicians should also consider reducing the dosage of the immunosuppressive medications or changing the drugs altogether for patients with a history of skin cancer.

Given that skin cancer can’t always be prevented in transplant recipients, patients should undergo regular screening. It’s highly recommended that transplant teams coordinate closely with dermatologists to ensure optimal patient care. Skin screenings are encouraged on a 6-month basis for patients with extensive sun damage or a history of skin cancer.

In addition to practicing daily sun protection, transplant recipients should examine their own skin regularly and consult a dermatologist immediately if anything suspicious is found.

Helpful Resources

To learn more about the incidence of skin cancer in transplant recipients, please visit UCSF Transplant Skin Cancer Network

 

 

Questions & Comments

Please send all questions and/or feedback to info@odt-alliance.org

Based on a webinar presentation by Sarah T. Arron, MD, PhD, Associate Professor of Dermatology and Associate Chief of the Dermatologic Surgery and Laser Center at the University of California, San Francisco. A special thanks to Dr. Arron for her contributions to this in-service.

 

Worth Sharing
V5I10

A Special Thanks to This Series’ Contributors

Fenton Deanna D
About the Editor |
Deanna Fenton

Deanna is a knowledgeable and versatile professional with diverse experiences in healthcare, client relations, marketing, project management and demonstrated skills in leadership and advocacy. Prior to joining The Alliance, she worked in Hospital Development at her local OPO in the state of New Jersey where she served as the clinical liaison to a number of Level 1 Trauma & Neuroscience centers as well as community hospitals. Her personal connection as a donor family and friend fuels her passion to support her colleagues across the donation-transplantation continuum through the development of valuable educational resources that ultimately boost performance and improve outcome measures. Deanna holds a Bachelor of Arts in Psychology and a minor degree in Public Health from Montclair State University. In her spare time, Deanna enjoys visiting vineyards, spending time with her family, and traveling in hopes of visiting all seven wonders of the world.

Advancing All.

The Alliance is not a membership organization and therefore relies on annual voluntary financial support from OPOs and transplant programs who find value in our programs and initiatives.

We invite you to join us as a professional partner